HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Hubbard, R. Articles by Fletcher, A. Search for Related Content PubMed PubMed Citation Articles by Hubbard, R. Articles by Fletcher, A.

Use of Inhaled Corticosteroids and the Risk of Fracture^*

^* From the Division of Epidemiology and Public Health (Drs. Hubbard, West, and Mr. Smith) and Division of Respiratory Medicine (Dr. Tattersfield), University of Nottingham, Nottingham; and Department of Epidemiology and Population Health (Drs. Smeeth and Fletcher), London School of Hygiene and Tropical Medicine, London, UK.

Correspondence to: Richard Hubbard, DM, Respiratory Medicine, Clinical Sciences Building, Nottingham City Hospital, NG5 1PB, Nottingham, UK; e-mail: Richard.Hubbard{at}nottingham.ac.uk

Abstract

Background: Previous studies have found an association between the use of inhaled corticosteroids and fracture, but the extent to which this association is due to inhaled corticosteroids or to related factors, such as the severity of airflow obstruction, is disputed. We report a new approach in which we combine data on people with airflow obstruction from a large Medical Research Council study of the assessment and management of older people in the community with longitudinal data from their computerized general practice records.

Methods: Our cohort includes 1,671 study participants with a diagnosis of asthma or COPD (mean age, 80.6 years). We determined the dose-response relationship between inhaled corticosteroid exposure and time to first fracture using Cox regression, allowing for a wide range of potential confounding factors.

Results: During a mean follow-up period of 9.4 years, 982 patients (59%) received a prescription for an inhaled corticosteroid and 187 patients had a fracture. After adjusting for the effects of age and gender, we found a dose-related increase in fracture risk with exposure to inhaled corticosteroids (rate ratio for mean daily dose > 601 µg, 2.53; 95% confidence interval [CI], 1.65 to 3.89; overall trend p < 0.0001). The results were similar after adjusting for oral corticosteroid exposure, airflow obstruction diagnosis, historical fracture, and bronchodilator use (rate ratio, 4.21; 95% CI, 2.19 to 8.13), and also in the subset of people with no exposure to oral corticosteroids (rate ratio, 4.54; 95% CI, 1.23 to 16.74).

Conclusions: Our findings provide further evidence that inhaled corticosteroid use is an independent risk factor for fracture.

Key Words: bone mineral density • cohort study • fracture • inhaled corticosteroids

This article has been cited by other articles:

				O. Kukoyi Selective Serotonin Reuptake Inhibitors and Risk of Fracture in Elderly Persons Arch Intern Med, November 26, 2007; 167(21): 2369 - 2369. [Full Text] [PDF]

				Inhaled Corticosteroids and Risk for Fracture Journal Watch (General), October 25, 2006; 2006(1025): 6 - 6. [Full Text]